{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:35:45Z","timestamp":1770485745959,"version":"3.49.0"},"reference-count":28,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[2013,9,1]]},"DOI":"10.1136\/archdischild-2013-303893","type":"journal-article","created":{"date-parts":[[2013,7,14]],"date-time":"2013-07-14T00:44:39Z","timestamp":1373762679000},"page":"686-691","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination"],"prefix":"10.1136","volume":"98","author":[{"given":"P. C. S.","family":"de Whalley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Plested","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nuthall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,7,13]]},"reference":[{"issue":"Suppl 2","key":"key-10.1136\/archdischild-2013-303893-1","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"key":"key-10.1136\/archdischild-2013-303893-2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modelling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.1136\/archdischild-2013-303893-3","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"key-10.1136\/archdischild-2013-303893-4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14\u2005months with meningococcal serogroup C conjugate vaccine in the Netherlands","volume":"25","author":"De Greeff","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/archdischild-2013-303893-5","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"key":"key-10.1136\/archdischild-2013-303893-6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal Serogroup C and Haemophilus influenzae Type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.1136\/archdischild-2013-303893-7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/INF.0b013e3181f728fd","article-title":"Persistence of immunity following a booster dose of Haemophilus influenzae type B-meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial","volume":"30","author":"Khatami","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/archdischild-2013-303893-8","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999\u20132000 and response to a booster: a Phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2013-303893-9","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1128\/CVI.05354-11","article-title":"Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood","volume":"18","author":"Khatami","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.1136\/archdischild-2013-303893-10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"Br Med J"},{"key":"key-10.1136\/archdischild-2013-303893-11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"key-10.1136\/archdischild-2013-303893-12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"key-10.1136\/archdischild-2013-303893-13","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1016\/j.vaccine.2007.04.071","article-title":"Vaccinating adolescents against meningococcal disease in Canada: A cost-effectiveness analysis","volume":"25","author":"De Wals","year":"2007","journal-title":"Vaccine"},{"issue":"ACS-3","key":"key-10.1136\/archdischild-2013-303893-14","first-page":"1","article-title":"Update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations: an advisory committee statement","volume":"2009","author":"Immunization NACo","year":"2009","journal-title":"Can Commun Dis Rep"},{"key":"key-10.1136\/archdischild-2013-303893-15","first-page":"72","article-title":"Updated recommendations for use of meningococcal conjugate vaccines-Advisory Committee on Immunization Practices (ACIP), 2010","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"Morbid Mortal Wkly Rep"},{"key":"key-10.1136\/archdischild-2013-303893-16","article-title":"Draft minute of the meeting on Wednesday 3 October 2012","author":"Joint Committee on Vaccination and Immunisation"},{"key":"key-10.1136\/archdischild-2013-303893-17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/508776","article-title":"Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3\u2005years after immunization","volume":"43","author":"Snape","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.1136\/archdischild-2013-303893-18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"Br Med J"},{"key":"key-10.1136\/archdischild-2013-303893-19","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1097\/INF.0b013e318224fb14","article-title":"Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria menigitidis given to adolescents previously immunized with a glycoconjugate vaccine","volume":"30","author":"de Whalley","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/archdischild-2013-303893-20","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells","volume":"108","author":"Kelly","year":"2006","journal-title":"Blood"},{"key":"key-10.1136\/archdischild-2013-303893-21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"key-10.1136\/archdischild-2013-303893-22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from post-licensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"key-10.1136\/archdischild-2013-303893-23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/INF.0b013e3180cc2c25","article-title":"Reconsideration of the use of meningococcal polysaccharide vaccine","volume":"26","author":"Granoff","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.1136\/archdischild-2013-303893-24","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","journal-title":"J Med Microbiol"},{"key":"key-10.1136\/archdischild-2013-303893-25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jinf.2012.09.008","article-title":"Epidemiology of invasive meningococcal disease in Germany, 2002\u20132010, and impact of vaccination with meningococcal C conjugate vaccine","volume":"66","author":"Hellenbrand","year":"2013","journal-title":"J Infect"},{"key":"key-10.1136\/archdischild-2013-303893-26","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1128\/CVI.05655-11","article-title":"Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction","volume":"19","author":"Ishola","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.1136\/archdischild-2013-303893-27","article-title":"Invasive meningococcal infections laboratory reports, England and Wales by capsular group & calendar year, 1998\u20132012","author":"Health Protection Agency"},{"key":"key-10.1136\/archdischild-2013-303893-28","unstructured":"Stoof S, van der Klis F, van Rooijen D, et al. Determining the appropriate age for a second immunization with meningococcal serogroup C conjugate vaccine; an intervention study among Dutch teenagers [Abstract P141]. In: XVIIIth International Pathogenic Neisseria Conference (IPNC), W\u00fcrzburg, Germany, 9\u201314 September 2012."}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2013-303893","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:32:44Z","timestamp":1601109164000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2013-303893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,13]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,8,13]]},"published-print":{"date-parts":[[2013,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/archdischild-2013-303893","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,13]]}}}